Our Pricing

Prescription Weight Loss Treatment - Order Online UK

Published on: June 03, 2026

Accessing prescription weight loss treatment online UK services has transformed how thousands of patients manage their weight journey. At Cured Pharmacy, our UK-registered clinical team provides evidence-based weight loss medications including Wegovy (semaglutide) from £79.00, with free online consultations completed in under three minutes and discreet delivery to your door.

How Prescription Weight Loss Injections Work

GLP-1 receptor agonists like semaglutide work by mimicking the action of glucagon-like peptide-1, a naturally occurring hormone that regulates appetite and food intake [1]. These medications slow gastric emptying, increase feelings of fullness after meals, and reduce hunger signals between the brain and digestive system.

In the landmark STEP 1 trial, adults using semaglutide 2.4mg weekly achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. Participants also demonstrated improvements in cardiovascular risk markers including blood pressure, cholesterol levels, and inflammatory markers [2].

The medication requires subcutaneous injection once weekly, typically in the abdomen, thigh, or upper arm. Most patients report the injection process becomes routine within the first few weeks, and our clinical team provides comprehensive guidance on proper injection technique during your consultation.

Wegovy (Semaglutide) for Weight Management

Wegovy contains semaglutide at a therapeutic dose specifically licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity [3]. The treatment follows a carefully structured dose escalation schedule to minimise gastrointestinal side effects.

Treatment begins at 0.25mg weekly for four weeks, gradually increasing every four weeks through 0.5mg, 1mg, and 1.7mg doses before reaching the maintenance dose of 2.4mg weekly. This gradual titration allows your body to adapt to the medication whilst reducing the likelihood of nausea and other common initial side effects [1].

At Cured Pharmacy, Wegovy is available from £79.00 per pen, significantly lower than typical market rates. All prescriptions are issued following clinical assessment by a UK-registered prescriber who will review your medical history, current medications, and weight management goals to ensure suitability.

Who Can Use Wegovy

Wegovy is suitable for adults who meet specific clinical criteria and have attempted lifestyle modifications including diet and exercise without achieving adequate weight loss. Your prescriber will assess contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastroparesis, or diabetic retinopathy [3].

The medication is not recommended during pregnancy or breastfeeding, and patients planning pregnancy should discontinue treatment at least two months before conception. Your UK prescriber will conduct a thorough medical assessment to ensure Wegovy represents a safe and appropriate treatment option for your individual circumstances.

Clinical Evidence and Expected Outcomes

The STEP clinical trial programme enrolled over 4,500 participants across five major studies, establishing semaglutide 2.4mg as one of the most effective pharmacological interventions for weight management currently available in the UK [1][2]. Beyond the headline weight loss figures, trials demonstrated sustained weight reduction when combined with lifestyle interventions.

In STEP 2, which specifically studied adults with type 2 diabetes, participants achieved an average weight reduction of 9.6% over 68 weeks, alongside improvements in glycaemic control with HbA1c reductions of 1.6% [4]. These dual benefits make GLP-1 treatments particularly valuable for patients managing both obesity and metabolic conditions.

Long-term data suggests weight loss plateaus typically occur between 60-68 weeks of treatment, with most patients maintaining their reduced weight whilst continuing medication [1]. Discontinuation often results in gradual weight regain, which is why prescribers typically recommend ongoing treatment as part of a comprehensive weight management programme including dietary modifications and increased physical activity.

Realistic Expectations and Individual Variation

Individual responses to prescription weight loss treatment vary considerably based on baseline weight, adherence to lifestyle modifications, genetic factors, and concurrent medications. Whilst clinical trials report average outcomes, some patients achieve substantially greater weight loss whilst others experience more modest results [2].

Your UK prescriber will establish realistic goals during your initial consultation and arrange appropriate follow-up to monitor progress, adjust dosing if necessary, and address any side effects. Successful weight management typically requires ongoing clinical support rather than medication alone.

Common Side Effects and Management Strategies

The most frequently reported side effects with semaglutide are gastrointestinal in nature, including nausea (44% of participants in STEP 1), diarrhoea (30%), vomiting (24%), and constipation (24%) [1]. These effects are typically mild to moderate in severity and diminish over time as your body adapts to the medication.

Practical management strategies include eating smaller, more frequent meals, avoiding high-fat foods that delay gastric emptying further, staying well-hydrated, and timing your injection consistently each week. Many patients find symptoms are most noticeable in the 24-48 hours following injection and improve as the week progresses.

Rare but serious side effects requiring immediate medical attention include signs of pancreatitis (severe abdominal pain radiating to the back), gallbladder problems (yellowing of skin or eyes, severe upper abdominal pain), or allergic reactions. Our clinical team provides comprehensive safety information during your consultation and remains available for ongoing support throughout your treatment journey.

How to Order Prescription Weight Loss Treatment Online UK

Ordering prescription weight loss treatment through Cured Pharmacy begins with a free online clinical consultation that takes under three minutes to complete. You'll provide information about your current weight, height, medical history, existing medications, and any previous weight loss attempts.

A UK-registered prescriber from our clinical team reviews your assessment, typically within 24 hours. If treatment is deemed suitable and safe for your individual circumstances, your prescription is issued electronically to our GPhC-registered pharmacy (registration number 9012511) where superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees dispensing.

Medications are dispatched in 100% discreet packaging with no external indication of contents. Standard delivery reaches most UK addresses within 2-3 working days, with tracked options available. We provide transparent upfront pricing with no hidden consultation fees—the price you see is the complete cost including clinical assessment, prescription, medication, and delivery.

Ongoing Prescriptions and Follow-Up

Weight loss treatment typically requires ongoing monthly prescriptions as you progress through dose escalation and maintenance phases. Cured Pharmacy makes reordering straightforward with automated reminders and streamlined repeat consultations to ensure continuity of treatment.

Your prescriber may request periodic updates on your weight loss progress, any side effects experienced, and overall tolerance of the medication. This ongoing clinical oversight ensures treatment remains appropriate and effective throughout your weight management journey.

Why Choose Cured Pharmacy for Weight Loss Treatment

As a fully registered UK online pharmacy, Cured Pharmacy operates under the regulatory oversight of the General Pharmaceutical Council, ensuring every aspect of our service meets the highest clinical and ethical standards. We supply only genuine UK-licensed medications sourced through authorised pharmaceutical wholesalers—never grey market or unlicensed imports.

Our transparent pricing model means you see the complete cost before beginning your consultation, with no surprise fees at checkout. We guarantee the lowest prices in the UK for prescription weight loss treatments, and our price match commitment ensures you're getting exceptional value without compromising on clinical quality or regulatory compliance.

The combination of expert clinical oversight from UK-registered prescribers, superintendent pharmacist supervision of every prescription, and discreet home delivery creates a convenient, professional service that thousands of UK patients trust for their weight management needs. Every consultation is conducted by qualified healthcare professionals who understand the complexities of obesity treatment and provide individualised recommendations based on your unique medical profile.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2022). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.